tolbutamide has been researched along with Adenoma, alpha-Cell in 4 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigated the interactions of calcium and somatostatin analogues on peptide release in two patients, one with a glucagonoma (patient A) and one with an insulinoma (patient B)." | 9.08 | Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma. ( O'Dorisio, TM; Thompson, CS; Woltering, EA, 1996) |
| "Thus, alpha-TC glucagonoma cells contain ATP-sensitive K+ channels that regulate glucagon release, yet allow inhibition of hormone release by glucose." | 5.29 | Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. ( Buettger, C; Epstein, AJ; Hang, TL; Matschinsky, FM; Ronner, P, 1993) |
| " This study investigated the interactions of calcium and somatostatin analogues on peptide release in two patients, one with a glucagonoma (patient A) and one with an insulinoma (patient B)." | 5.08 | Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma. ( O'Dorisio, TM; Thompson, CS; Woltering, EA, 1996) |
| "Thus, alpha-TC glucagonoma cells contain ATP-sensitive K+ channels that regulate glucagon release, yet allow inhibition of hormone release by glucose." | 1.29 | Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. ( Buettger, C; Epstein, AJ; Hang, TL; Matschinsky, FM; Ronner, P, 1993) |
| "All of the clinical manifestations of glucagonoma syndrome so far reported in the literature were noted but there was no evidence indicating the presence of multiple endocrine adenomatosis." | 1.26 | A case with glucagonoma syndrome--endocrine and metabolic studies. ( Fukushima, H; Kitoh, M; Konno, T; Takemiya, M; Uzawa, H; Yamaguchi, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hendriks, T | 1 |
| Jansen, JB | 1 |
| van Tongeren, JH | 1 |
| Fukushima, H | 1 |
| Yamaguchi, K | 1 |
| Uzawa, H | 1 |
| Kitoh, M | 1 |
| Takemiya, M | 1 |
| Konno, T | 1 |
| Ronner, P | 1 |
| Matschinsky, FM | 1 |
| Hang, TL | 1 |
| Epstein, AJ | 1 |
| Buettger, C | 1 |
| Thompson, CS | 1 |
| O'Dorisio, TM | 1 |
| Woltering, EA | 1 |
1 trial available for tolbutamide and Adenoma, alpha-Cell
| Article | Year |
|---|---|
Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
Topics: Antineoplastic Agents, Hormonal; Calcium; Glucagon; Glucagonoma; Humans; Hypoglycemic Agents; Infusi | 1996 |
3 other studies available for tolbutamide and Adenoma, alpha-Cell
| Article | Year |
|---|---|
The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
Topics: Adenoma, Islet Cell; Arginine; Calcitonin; Calcium; Chromatography, Gel; Fasting; Female; Glucagon; | 1984 |
A case with glucagonoma syndrome--endocrine and metabolic studies.
Topics: Adenoma, Islet Cell; C-Peptide; Endocrine Glands; Female; Glucagon; Glucagonoma; Glucose Tolerance T | 1981 |
Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Binding, Competitive; Diazoxide; Glucagon; Glucagono | 1993 |